lacosamide 200 mg
1 INDICATIONS AND USAGE Lacosamide tablets are indicated for: Treatment of partial-onset seizures in patients 4 years of age and older (1.1) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older (1.2) 1.1 Partial-Onset Seizures Lacosamide tablets are indicated for the Treatment of partial-onset seizures in patients 4 years of age and older. 1.2 Primary Generalized Tonic-Clonic Seizures Lacosamide is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older. Additional pediatric use information is approved for UCB, Inc.’s VIMPAT ® (lacosamide) tablets. However, due to UCB, Inc.’s marketing exclusivity rights, this drug product is not labeled with that information.
amneal pharmaceuticals llc
OVAL BLUE A926
A926 OVAL BLUE
Related Pills
lacosamide 200 mg
amneal pharmaceuticals llc
lacosamide 150 mg
amneal pharmaceuticals llc
lacosamide 100 mg
amneal pharmaceuticals llc
lacosamide 50 mg
amneal pharmaceuticals llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
LACOSAMIDE tablets, USP 50 mg are supplied as pink, oval shaped, film-coated tablets debossed with "A93" on one side and plain on the other side. They are available as follows: Bottles of 60: NDC 65162-923-06 Bottles of 500: NDC 65162-923-50
LACOSAMIDE tablets, USP 100 mg are supplied as dark yellow, oval shaped, film-coated tablets debossed with "A924" on one side and plain on the other side. They are available as follows: Bottles of 60: NDC 65162-924-06 Bottles of 500: NDC 65162-924-50
LACOSAMIDE tablets, USP 150 mg are supplied as beige, oval shaped, film-coated tablets debossed with "A925" on one side and plain on the other side. They are available as follows: Bottles of 60: NDC 65162-925-06 Bottles of 500: NDC 65162-925-50
LACOSAMIDE tablets, USP 200 mg are supplied as blue, oval shaped, film-coated tablets debossed with "A926" on one side and plain on the other side. They are supplied as follows: Bottles of 60: NDC 65162-926-06 Bottles of 500: NDC 65162-926-50 16.2 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
More pills like OVAL A926